Actively Recruiting
Integrated Diagnostics for Early Diagnosis of Liver Disease
Led by Manchester University NHS Foundation Trust · Updated on 2026-02-09
1200
Participants Needed
1
Research Sites
336 weeks
Total Duration
On this page
Sponsors
M
Manchester University NHS Foundation Trust
Lead Sponsor
U
University of Manchester
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is an observational study that will explore the hypothesis that by combining data from patients with liver disease with novel blood biomarkers, single nucleotide polymorphism (SNP) analysis and faecal microbiome analysis. The Investigators will improve diagnosis of liver fibrosis compared to the current available diagnostic tools.
CONDITIONS
Official Title
Integrated Diagnostics for Early Diagnosis of Liver Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All patients referred to Community Liver Assessment Clinic.
- Male or female over 18 years of age.
- Females must be non-pregnant and non-lactating.
You will not qualify if you...
- Age under 18 years.
- Pregnancy or breast-feeding. Women of childbearing potential must have a negative blood serum pregnancy test.
- Isolated bilirubinaemia.
- Known pre-existing liver disease.
- Being acutely unwell.
- Suspected malignancy.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Manchester University NHS Foundation Trust
Manchester, Greater Manchester, United Kingdom, M13 9WL
Actively Recruiting
Research Team
V
Varinder Athwal
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here